INS and type 1 diabetes mellitus: To prove the safety and effectiveness of the nonadjunctive use of CGM sensors, our research group is developing the T1D decision-making (T1D-DM) model, i.e., a model of T1D patients making SMBG-based or CGM-based treatment decisions, like insulin dosing or CHO intake [51].